Recognition and treatment of genitourinary complications in paediatric Crohn's disease using Infliximab

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 7, 2010, Pages 1042-1046

  Afzal, N A ^a   Shenoy, M U ^b   Haque, S ^b   Wilcox, D T ^b   Shah, N ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; Fistula; Inflammatory bowel disease; Infliximab; Nephrolithiasis; Paediatrics; Renal; Stone; Surgery; Urinary tract

Indexed keywords

AMIKACIN; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; METRONIDAZOLE; MYCOPHENOLIC ACID; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; SALICYLIC ACID;

ABDOMINAL ABSCESS; ARTICLE; BLADDER FISTULA; CHILD; CLINICAL ARTICLE; COLITIS; COLON RESECTION; CROHN DISEASE; FEMALE; GENITAL ULCER; HUMAN; HYDRONEPHROSIS; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FISTULA; LAPAROTOMY; MALE; PENILE SWELLING; PRIORITY JOURNAL; URETHRA STRICTURE; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CHILD; CROHN DISEASE; FEMALE; FEMALE UROGENITAL DISEASES; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONDON; MALE; MALE UROGENITAL DISEASES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77953189704     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01731.x     Document Type: Article

References (27)

1. Ben Ami H, Ginesin Y, Behar DM, Fischer D, Edoute Y, Lavy A. Diagnosis and treatment of urinary tract complications in Crohn's disease: an experience over 15 years. Can J Gastroenterol 2002 16 : 225 229.
2. Kleinhans G, Leusmann D, Pohl J, Pott G. Urologic complications in 200 patients with Crohn disease. Z Gastroenterol 1985 23 : 362 374. (Pubitemid 15235045)
3. Joy HM, Fairhurst JJ, Beattie RM. Renal calculus at presentation in a child with Crohn's disease. Pediatr Radiol 2003 33 : 250 252.
4. Clark JH, Fitzgerald JF, Bergstein JM. Nephrolithiasis in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1985 4 : 829 834.
5. Simoneaux SF, Patrick LE. Genitourinary complications of Crohn's disease in pediatric patients. AJR Am J Roentgenol 1997 169 : 197 199.
6. Barabino A, Castellano E, Gandullia P, Biscaldi E. A girl with severe fistulizing Crohn's disease. Dig Liver Dis 2000 32 : 792 794.
7. Rampton DS, Denyer ME, Clark CG, Sarner M. Recto-urethral fistula in Crohn's disease. Br J Surg 1982 69 : 233.
8. Manganiotis AN, Banner MP, Malkowicz SB. Urologic complications of Crohn's disease. Surg Clin North Am 2001 81 : 197 215. x.
9. van Dongen LM, Lubbers EJ. Fistulas of the bladder in Crohn's disease. Surg Gynecol Obstet 1984 158 : 308 310.
10. McNamara MJ, Fazio VW, Lavery IC, Weakley FL, Farmer RG. Surgical treatment of enterovesical fistulas in Crohn's disease. Dis Colon Rectum 1990 33 : 271 276.
11. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999 340 : 1398 1405. (Pubitemid 29205403)
12. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004 350 : 876 885.
13. Lionetti P, Bronzini F, Salvestrini C, Bascietto C, Canani RB, De Angelis GL, et al. Response to infliximab is related to disease duration in paediatric Crohn's disease. Aliment Pharmacol Ther 2003 18 : 425 431.
14. Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, et al. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol 2003 98 : 833 838.
15. Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol 2000 95 : 3189 3194.
16. Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J Pediatr 2000 137 : 192 196.
17. Teitelbaum JE, Saeed S, Triantafyllopoulou M, Daum F. Infliximab in pediatric Crohn disease patients with enterovesicular fistulas. J Pediatr Gastroenterol Nutr 2007 44 : 279 282.
18. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents. recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005 41 : 1 7.
19. Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease. Am J Gastroenterol 2004 99 : 445 449.
20. Talamini MA, Broe PJ, Cameron JL. Urinary fistulas in Crohn's disease. Surg Gynecol Obstet 1982 154 : 553 556.
21. Solem CA, Loftus EV Jr., Tremaine WJ, Pemberton JH, Wolff BG, Sandborn WJ. Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol 2002 97 : 2300 2305.
22. Gruner JS, Sehon JK, Johnson LW. Diagnosis and management of enterovesical fistulas in patients with Crohn's disease. Am Surg 2002 68 : 714 719.
23. Koelbel G, Schmiedl U, Majer MC, Weber P, Jenss H, Kueper K, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol 1989 152 : 999 1003.
24. Escher JC, Stoof TJ, van Deventer SJ, van Furth AM. Successful treatment of metastatic Crohn disease with infliximab. J Pediatr Gastroenterol Nutr 2002 34 : 420 423.
25. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007 44 : 265 267.
26. Mackey AC, Green L, Leptak C, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr 2009 48 : 386 388.
27. Kugathasan S. Prolonged duration of response to infliximab in early pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 2001 33 (Suppl. 1 S40 3.